Sekisui Chemical Co., Ltd. · TSE:4204
Sekisui Chemical — Q3 2025 Earnings Presentation
31 slides from Sekisui Chemical's earnings presentation, Jan 29, 2026
Slide 1: Presentation of Financial Results for 3Q
SEKISUI CHEMICAL CO., LTD. FY2025, ending March 31, 2026 Presentation of Financial Results for 3Q Ikusuke Shimizu Representative Director Senior Managing Executive Officer January 29, 2026
Slide 2: Results for 3Q and Forecasts for FY2025
Results for 3Q and Forecasts for FY2025 FY2024 FY2025 Forex Rate 4Q Plan 2H Plan 3Q 4Q 2H 3Q 4Q 2H (Oct.) (Oct.) In-house ¥148/US$ ¥156/US$ ¥155/US$ ¥148/US$ ¥148/US$ assumptions ‐ ‐ ‐ ¥172/€ ¥183/€ ¥181/€ ¥172/€ ¥172/€ Results ¥152/US$ ¥153/US$ ¥152/US$ ¥154/US$ (Avg. rate for ‐ ‐ ‐ ‐ each term) *
Slide 3: Overview of 3Q FY2025 and 1Q-3Q Results
Overview of 3Q FY2025 and 1Q-3Q Results ▌ Increase in net sales; record high net sales in the 3Q ▌ Despite a decrease in the 3Q, operating profit and ordinary profit generally in line with plans (Oct.) ▌ Following completion of a demonstration experiment in the Biorefinery Business, Kuji Plant disma
Slide 4: 3Q FY2025 and 1Q-3Q Results by Segment
3Q FY2025 and 1Q-3Q Results by Segment ▌ Increase in net sales and operating profit in the HPP and Housing companies ; Group-wide operating profit in the 3Q generally in line with plans (Oct.) ▌ Other breakdown: PV* down ¥1.2 billion, LB* down ¥0.1 billion, BR* down ¥0.5 billion, R&D and other down
Slide 5: Outlook for Market Conditions
Outlook for Market Conditions Housing・Visitors (YoY) * Figures in parentheses: Forecast (Oct) Number of Automobiles Manufactured (YoY) Substantial decline in exhibition visitors; overall visitor trends also While slightly above forecasts (Oct.), 3Q trends below the previous below the previous year;
Slide 6: 2H FY2025 Forecasts by Segment
2H FY2025 Forecasts by Segment ▌ Increase in net sales in three segments, excluding the Medical Business, as well as Group-wide; operating profit forecast to increase across all segments ▌ Other breakdown: PV down ¥2.4 billion, LB down ¥0.2 billion, BR down ¥1.1 billion, R&D and other down ¥3.3 bill
Slide 7: 2H FY2025 Forecasts by Segment (3Q & 4Q)
2H FY2025 Forecasts by Segment (3Q & 4Q) ▌ Forecasting increases in net sales and operating profit in four segments as well as Group-wide in the 4Q ▌ Following the 3Q, the 4Q also expected to largely progress in line with plans (Oct.) 4Q FY2025 3Q FY2024 3Q FY2025 Difference 4Q FY2024 Difference For
Slide 8: 2H FY2025 Forecasts Analysis
2H FY2025 Forecasts Analysis ▌ Despite the significant impact of ongoing weak conditions both in Japan and overseas and sales volumes & product mix falling below plans (Oct.), net sales and operating profit forecast to increase in line with plans (Oct.) on the back of an improvement in raw materials
Slide 9: FY2025 Forecasts by Segment
FY2025 Forecasts by Segment ▌ Forecasting increases in net sales and operating profit in three segments, excluding the Medical Business , as well as Group-wide ▌ Other breakdown: PV down ¥4.3 billion, LB down ¥0.6 billion, BR down ¥2.1 billion, R&D and other down ¥6.3 billion FY2025 FY2025 FY2024 Di
Slide 10: FY2025 Forecasts and Returns to Shareholders
FY2025 Forecasts and Returns to Shareholders ▌ Forecasting increases in net sales and operating profit and ordinary profit to record highs ▌ Bottom line forecast to come in in line with plans (Oct.) ▌ Dividend per share in line with plans (Oct.); plans to pay an annual dividend of ¥80 per share, up
Slide 11: Consolidated Performance
Consolidated Performance ▌ Steady growth even amid changes in the external environment; preparations progressing steadily toward the next Medium-Term Plan and Long-term Vision (JPY billion) EBITDA 119.3 126.7 133.4 137.7 137.3 133.2 116.6 137.6 142.1 147.1 161.7 168.6 175.0 1,410.0 1,297.8 1,327.9 1
Slide 12: HPP: 2H FY2025 Forecasts Analysis
HPP 2H FY2025 Forecasts Analysis Company ▌ Despite sales volumes & product mix falling below plans (Oct.) mainly in the Electronics field, growth on a YoY basis; net sales and operating profit forecast to increase in line with plans (Oct.) on the back of an improvement in raw materials, efforts to c
Slide 13: HPP: Three Strategic Fields
HPP Three Strategic Fields Company Net Sales Trends and KPIs in the Three Strategic Fields Growth Growth 11 businesses clarified as strengthening the current PF driving potential in the Drive 2.0 Medium-term Management Plan. Electronics Mobility Molding products, Electronics (semiconductor and Mobil
Slide 14: Housing: 2H FY2025 Forecasts Analysis
Housing 2H FY2025 Forecasts Analysis Company ▌ Increase in net sales and substantial upswing in operating profit across the Company as a whole; expected to achieve plans (Oct.) • Housing: Despite the continued slump in market conditions, increases in net sales and operating profit owing to higher un
Slide 15: Housing: KPIs by Business
Housing KPIs by Business Company Housing Business Renovation Business <Amount of Orders and the Number of (YoY) New Housing Orders Buildings by Type of Construction> Renovation Orders • Amount of orders progressing in line with plans (Oct.) FY25 1H 3Q 4Q 2H owing to the growth in orders for high-pri
Slide 16: UIEP: 2H FY2025 Forecasts Analysis
UIEP 2H FY2025 Forecasts Analysis Company ▌ Sluggish growth in sales volumes & product mix owing to continued weak housing market conditions as well as extended non-residential construction periods ▌ Despite falling below plans (Oct.) owing to the significant impact of ongoing weak conditions in the
Slide 17: UIEP: Three Strategic Fields
UIEP Three Strategic Fields Company Net sales in the Three Strategic Fields and KPI’s Building and Performance Construction and Fire resistant and non- Pipe Systems flammable materials materials (railroad industrial piping Infrastructures Composite Materials sleepers, etc.) • Piping materials: Decre
Slide 18: Medical: 2H FY2025 Forecasts Analysis
Medical 2H FY2025 Forecasts Analysis Business ▌ Efforts aimed at controlling fixed costs forecast to offset ongoing harsh overseas diagnostics trends and results falling below plans (Oct.) ▌ Operating profit forecast to increase in line with plans (Oct.) in overall terms Net Sales Analysis of Operat
Slide 19: Medical: Overview by Business
Medical Overview by Business Business Net sales by Business and Overview of Progress Overseas testing Diagnostics (Japan) Diagnostics (overseas) system • 3Q: Trends in excess of forecasts (Oct.) owing to the early spread of • 3Q: In addition to delays in the outbreak of infectious diseases in the in
Slide 20: Financial Results 3Q FY2025
Financial Results 3Q FY2025 19
Slide 21: Number and Impact of Changes in Consolidated Companies
Number and Impact of Changes in Consolidated Companies Number of Consolidated Companies Mar. 31, 2025 Dec. 31, 2025 Difference Consolidated Increased: 2 Subsidiaries*1 subsidiaries 145 142 Decreased: 5 Subsidiaries*2 Affiliates Increased: 0 Subsidiaries 6 6 (Equity Method) Decreased: 0 Subsidiaries
Slide 22: Summary of Profit and Loss
Summary of Profit and Loss + 1Q-3Q 1Q-3Q (JPY billion) Difference FY2024 FY2025 Net sales 955.3 959.9 +4.6 Gross profit 310.4 311.2 +0.8 Foreign exchange profits : +4.0 Gross profit margin 32.5% 32.4% -0.1% Selling, general and administrative expenses 233.0 238.3 +5.2 Foreign exchange profits : +3.2
Slide 23: Balance Sheets (Assets)
Balance Sheets (Assets) Dec.31 Inventories (B/S item) 2025 Difference Ready-built housing (products) 35.5 +2.2 Prepared land for subdivision Mar. 31, 2025 Dec. 31, 2025 Difference housing 77.6 +8.4 (JPY billion) Land under preparation (work in process) 7.9 -1.8 Housing under construction Cash and de
Slide 24: Balance Sheets (Liabilities & Net Assets)
Balance Sheets (Liabilities & Net Assets) Green Bond: +20.0 (JPY billion) Mar. 31, 2025 Dec. 31, 2025 Difference Non-interest-bearing liabilities 384.6 383.1 -1.4 Interest-bearing liabilities 110.8 165.7 +54.9 Net profit: +47.8 [Net interest-bearing liabilities] [-31.8] [55.8] [+87.6] Dividends paid
Slide 25: Consolidated Cash Flows
Consolidated Cash Flows 1Q-3Q FY2024 1Q-3Q FY2025 (JPY billion) Cash flows from operating activities 68.7 52.8 Cash flows from investing activities -34.8 -64.4 Cash flows from financing activities -54.7 -11.8 Net increase in cash and cash equivalents -19.1 -15.9 Free cash flow =Cash flows from opera
Slide 26: Depreciation, Amortization, Capital Expenditures, R&D Expenditure
Depreciation, Amortization, Capital Expenditures, Research and Development Expenditure 1Q-3Q 1Q-3Q FY2025 Difference FY2024 Difference (JPY billion) FY2024 FY2025 Forecasts Depreciation*1 37.9 41.2 +3.3 51.1 56.4 +5.3 Goodwill and other amortization*2 2.0 1.7 -0.3 2.6 2.2 -0.4 Capital expenditures 4
Slide 27: Forward-Looking Statements
This slide presentation contains forward-looking statements. These statements are based on current expectations and beliefs. However, actual results may differ from those expressed or implied due to a number of factors and uncertainties such as changes in the global economy and our business, competi
Slide 28: Housing Company Results and Forecasts
Housing Company Results and Forecasts Main data in Housing business 5ｚｚｚｚｚｚｚｚｚｚｚｚｚ FY2025 FY2024 2H Annual FY2023 1H 1H 2H Annual Forecasts Forecasts 3Q 3Q Net sales (JPY billion) 258.6 136.4 280.8 539.4 253.7 132.0 270.4 524.0 529.7 CONSOLIDATED Housing 167.1 89.5 176.4 343.5 165.2 86.5 172.2 337.3
Slide 29: Various Performance Data
Various Performance Data Group-wide FY2025 FY2024 FY2023 FY2022 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q HPP 108.2 115.3 114.2 - 110.6 110.5 112.0 114.2 96.1 104.2 106.0 106.6 99.1 102.4 97.9 97.0 Housing 128.4 130.3 136.4 - 116.2 137.4 132.0 138.4 121.0 143.8 126.7 1
Slide 30: Various Performance Data
Various Performance Data Industrial field FY2025 FY2024 FY2023 FY2022 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Labor-saving product 6.4 6.6 6.1 - 5.9 5.9 5.9 7.0 4.9 5.2 4.8 5.6 6.0 5.6 4.8 5.3 Environmentally friendly product 1.8 2.1 2.3 - 1.9 1.9 2.2 2.2 1.7 2.1 2.0
Slide 31: SEKISUI
SEKISUI Copyright© SEKISU! CHEMICAL CO., LTD.